Banner - Practice Academy Virtual Conference, June 11, 2026
Logo Image
News|Videos|December 4, 2024

GLP-1 RA antiobesity medications: Predictions for the future

Listen
0:00 / 0:00

Key Takeaways

  • GLP-1 RA drugs represent a major advancement in obesity treatment, indicating a paradigm shift in managing the condition.
  • New pharmacological options for obesity are expected to emerge soon, enhancing treatment possibilities.
SHOW MORE

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

GLP-1 RA drugs are an important step in changing the treatment of obesity. There is a paradigm shift in thinking about obesity, and new drugs will come in a relatively short period of time. Meanwhile, “the cost clearly has to come down,” said Robert Kushner, MD, an expert researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.

Related Content

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more